Part of Phaidon International
Part of Phaidon International
Showing 116 results
Sort by:
Senior Oncology Sales Specialist Location: Boston, MA (New England)Base Salary: $180,000-$220,000OverviewGrowing oncology biotech seeking a Senior Oncology Sales Specialist to drive adoption and utilization of a targeted oncology therapy across New England. This individual will develop strategic territory plans, build relationships with key oncolog...
Medical Director, Medical AffairsLocation: Morristown, NJ (Hybrid); remote East Coast candidates may be considered EPM Scientific is partnered with a growing clinical-stage biotech seeking a Medical Director, Medical Affairs to lead medical strategy for novel late-phase therapies targeting serious metabolic and liver diseases. Reporting to the Head...
Role: Director of Quality Location: Irvine, CA (Hybrid) Salary: $180,000 - $225,000EPM is partnered with a rapidly growing medical device company focused on developing breakthrough structural heart technologies to address complex cardiovascular conditions. With strong clinical momentum, expanding commercial adoption, and a robust product pipeline, ...
Take the first step toward your next opportunity - submit your resume and get started today.
SVP, Healthcare Media Business Unit Lead EPM Scientific is partnered with an established healthcare media and education organization investing in two new commercial businesses: a programmatic HCP media offering and a healthcare data products business. The organization is seeking an entrepreneurial senior leader to refine the strategy, build the ini...
Account Director, Medical Education AgencyA growing healthcare communications and medical education agency is seeking an Account Director to lead key pharmaceutical and biotech client relationships. This individual will serve as the senior day-to-day client contact, providing strategic counsel, overseeing program execution, managing budgets, and dr...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...